Skip to main content
Lyrea avatar

Not yet reviewed — this article is pending editorial review by Lyrea.

Citation noticeOur citation system is being overhauled

References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.

LAE-32

This article is a stubmissing:
Subjective Effects
Pharmacology
Interactions
Tolerance
History & Culture
LAE-32 molecule structureLAE-32 molecule structure
Chemical Class
Lysergamide

Dosage & Duration

Dosage

Doses are population estimates that vary widely between individuals.

Moderate500-1500 µg

Duration

Total4-10 hours

Subjective Effects

Subjective Effects not written up yet

Pharmacology

Pharmacology not written up yet

Interactions

Interactions not written up yet

An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.

Check TripSit

Tolerance

Tolerance not written up yet

Harm Potential

Psychosis Risk

LAE-32 has been reported to induce a schizophrenia-like condition characterized by depersonalization and indifference in mentally healthy individuals. The substance's primary psychological effects appear to involve significant dissociative and depersonalizing states that resemble psychotic symptomatology.

History & Culture

History & Culture not written up yet

Legality

International

The quoted legal-status section does not identify any nation where LAE-32 is directly banned.

By Country

Illegal1
United States flagUnited StatesIllegal (analog/blanket ban)

References

Citations

  1. PubChem PUG REST — D-Lysergic acid monoethylamide synonyms (CID 101704). pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/101704/synonyms/JSON1
  2. PubChem PUG REST — Lysergic acid ethylamide properties (CID 12304966). pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/12304966/property/Title,IUPACName,MolecularFormula,IsomericSMILES,CanonicalSMILES/JSON1
  3. PubChem PUG REST — (+)-Lysergic acid diethylamide properties (CID 5761). pubchem.ncbi.nlm.nih.gov (n.d.). https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/cid/5761/property/Title,IUPACName,MolecularFormula,IsomericSMILES,CanonicalSMILES/JSON1
  4. The inhibitory effect of methergoline on LAE-32-induced head-twitches in mice. pubmed.ncbi.nlm.nih.gov (n.d.). https://pubmed.ncbi.nlm.nih.gov/19604948/1
  5. Lists of Scheduling Actions, Controlled Substances, Regulated Chemicals — August 2026. deadiversion.usdoj.gov (n.d.). https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf1
  6. 2025 Code of Federal Regulations, Title 21, Part 1308 — Schedules of Controlled Substances. govinfo.gov (n.d.). https://www.govinfo.gov/content/pkg/CFR-2025-title21-vol9/xml/CFR-2025-title21-vol9-part1308.xml1
  7. DEA Diversion Control Division — Controlled Substance Schedules. deadiversion.usdoj.gov (n.d.). https://www.deadiversion.usdoj.gov/schedules/schedules.html1
  8. 21 U.S.C. § 802 — Definitions. uscode.house.gov (n.d.). https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section802&num=0&edition=prelim1
  9. 21 U.S.C. § 813 — Treatment of controlled substance analogues. uscode.house.gov (n.d.). https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section813&num=0&edition=prelim1
  10. 21 U.S.C. § 841 — Prohibited acts A. uscode.house.gov (n.d.). https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title21-section841&num=0&edition=prelim1

Article Status

  • Josie Kins avatar
    Step 1 · Automated synthesis

    An autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.

  • Step 2 · First-pass reviewPending

    Not yet reviewed — this article is pending editorial review by Lyrea.

  • Step 3 · Citation reviewPending

    No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.

Recent changes7 human edits · latest

Times are UTCNewest first

24 January 2026

  1. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  2. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  3. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  4. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  5. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  6. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

  7. Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more

All changes to this article · Site-wide recent changes

Suggest an edit

Spotted a mistake, an outdated claim, or something missing from the LAE-32 article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.

Wish to give generalised feedback? You can do so here.